Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition

REFERENCES

• Taylor , W. J. , Schumacher , H. R. Jr , Baraf , H. S. , Chapman , P. , Stamp , L. , Doherty , M. , McQueen , F. , Dalbeth , N. , Schlesinger , N. , Furst , D. E. , Vazquez-Mellado , J. , Becker , M. A. , Kavanaugh , A. , Louthrenoo , W. , Bardin , T. , Khanna , D. , Simon , L. S. , Yamanaka , H. , Choi , H. K. , Zeng , X. , Strand , V. , Grainger , R. , Clegg , D. , Singh , J. A. , Diaz-Torne , C. , Boers , M. , Gow , P. and Barskova , V. G. 2008 . A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout . Ann. Rheum. Dis. , 67 : 888 – 891 .
   PubMedGoogle Scholar
• Zhang , W. , Doherty , M. , Pascual , E. , Bardin , T. , Barskova , V. , Conaghan , P. , Gerster , J. , Jacobs , J. , Leeb , B. , Lioté , F. , McCarthy , G. , Netter , P. , Nuki , G. , Perez-Ruiz , F. , Pignone , A. , Pimentão , J. , Punzi , L. , Roddy , E. , Uhlig , T. and Zimmermann-Gòrska , I. 2006 . EULAR Standing Committee for International Clinical Studies Including Therapeutics: EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) . Ann. Rheum. Dis. , 65 : 1301 – 1311 .
   PubMed Web of Science ®Google Scholar
• Zhang , W. , Doherty , M. , Bardin , T. , Pascual , E. , Barskova , V. , Conaghan , P. , Gerster , J. , Jacobs , J. , Leeb , B. , Lioté , F. , McCarthy , G. , Netter , P. , Nuki , G. , Perez-Ruiz , F. , Pignone , A. , Pimentão , J. , Punzi , L. , Roddy , E. , Uhlig , T. and Zimmermann-Gòrska , I. 2006 . EULAR Standing Committee for International Clinical Studies Including Therapeutics: EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) . Ann. Rheum. Dis. , 65 : 1312 – 1324 .
   PubMed Web of Science ®Google Scholar
• Hakoda , M. , Masunari , N. , Yamada , M. , Fujiwara , S. , Suzuki , G. , Kodama , K. and Kasagi , F. 2005 . Serum uric acid concentration as a risk factor for cardiovascular mortality: a long-term cohort study of atomic bomb survivors . J. Rheumatol. , 32 : 906 – 912 .
   PubMed Web of Science ®Google Scholar
• Paulus , H. E. , Schlosstein , L. H. , Godfrey , R. G. , Klinenberg , J. R. and Bluestone , R. 1974 . Prophylactic colchicine therapy of intercritical gout: a placebo-controlled study of probenecid-treated patients . Arthritis Rheum. , 17 : 609 – 614 .
   PubMed Web of Science ®Google Scholar
• Man , C. Y. , Cheung , I. T. , Cameron , P. A. and Rainer , T. H. 2007 . Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamolcombination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial . Ann. Emerg. Med. , 49 : 670 – 677 .
   PubMed Web of Science ®Google Scholar
• Janssens , H. J. , Janssen , M. , van de Lisdonk , E. H. , van Riel , P. L. and van Weel , C. 2008 . Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial . Lancet , 371 : 1854 – 1860 .
   PubMed Web of Science ®Google Scholar
• Siu , Y. P. , Leung , K. T. , Tong , M. K. and Kwan , T. H. 2006 . Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level . Am. J. Kidney Dis. , 47 : 51 – 59 .
   PubMed Web of Science ®Google Scholar
• Shoji , A. , Yamanaka , H. and Kamatani , N. 2004 . A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy . Arthritis Rheum. , 51 : 321 – 325 .
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz , F. , Calabozo , M. , Pijoan , J. I. , Herrero-Beites , A. M. and Ruibal , A. 2002 . Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout . Arthritis Rheum. , 47 : 356 – 370 .
   PubMed Web of Science ®Google Scholar
• Campion , E. W. , Glynn , R. J. and DeLabry , L. O. 1987 . Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study . Am. J. Med. , 82 : 421 – 426 .
   PubMedGoogle Scholar
• Yamanaka , H. , Togashi , R. , Hakoda , M. , Terai , C. , Kashiwazaki , S. , Dan , T. and Kamatani , N. 1988 . Optimal range of serum urate concentrations to minimize risk of gouty attacks during anti-hyperuricemic treatment . Adv. Exp. Med. Biol. , 431 : 13 – 18 .
   Google Scholar
• Choi , H. K. and Ford , E. S. 2007 . Prevalence of the metabolic syndrome in individuals with hyperuricemia . Am. J. Med. , 120 : 442 – 447 .
   PubMed Web of Science ®Google Scholar
• Choi , H. K. and Curhan , G. 2004 . Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey . Arthritis Rheum. , 51 : 1023 – 1029 .
   PubMed Web of Science ®Google Scholar
• Choi , H. K. , Liu , S. and Curhan , G. 2005 . Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey . Arthritis Rheum. , 52 : 283 – 289 .
   PubMed Web of Science ®Google Scholar
• Choi , J. W. , Ford , E. S. , Gao , X. and Choi , H. K. 2008 . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey . Arthritis Rheum. , 59 : 109 – 116 .
   PubMed Web of Science ®Google Scholar